含吡啶、噻吩环大环化合物的合成及其与Cu(Ⅱ)的配合行为

以2，6－二溴甲基吡啶及2，5－二氯甲基噻吩分别与对甲基苯磺酰胺进行缩合反应得到新的大环化合物1，9，17，25－四对甲基苯磺酰基大环多胺｛[32]-Py4N4Ts4｝与1，8，15，22－四对甲基苯磺酰基大环化合物｛[28]-Th4N4Ts4｝。其中[32]－Py4N4Ts4在浓硫酸中脱去四个对甲基苯磺酰基后又得到新的大环多胺化合物[32]-Py4N4H4，并由紫外吸收光谱测定出其与Cu（Ⅱ）配合的配位比为1：2，证明形成了双核配合物。     

含吡啶环氮(王)冠的合成

本文报道了新的含吡啶环的氮(王)冠的合成。以活泼双功能团化合物2,6-二(溴四基)-吡啶和N-对甲苯磺酰基取代的多乙撑基多胺(二乙撑三胺,三乙撑四胺)二钠盐直接缩合成环,得到含吡啶环的氮(王)冠化合物:3,6,9-三对甲苯磺酰基-3,6,9,15-四氮双环[9.3.1]十五环-1(15),11,13-三烯(A)和3,6,9,12-四对甲苯磺酰基-3,6,9,12,18-五氮双环[12.3.1]十八环-1(18),14,16-三烯(B)。(A)和(B)经用30%的HBr-CH_3COOH溶液处理,得到3,6,9,15-四氮双环[9.3.1]十五环-1(15),11,13-三烯(C)和3,6,9,12,18-五氮双环[12.3.1]十八环-1(18),14,16-三烯(D)。以上化合物均经元素分析、IR和1~H NMR.等鉴定。这种直接缩合的方法,具有反应条件温和、设备简单、操作简便等优点。     

大二环型侧向穴醚的合成

本文报道一个大二环型侧向穴醚的合成方法借2,6-二(溴甲基)吡啶与β-(N-对甲苯磺酰基)丙氨酸酯缩合,产物经水解成酸后转换为酰氯(8),8借高度稀释法与1,7-二氮杂-4,10-二硫杂环十二烷(5)缩合成环,然后还原羰基.脱对甲苯磺酰基后得大二环型侧向穴醚1,5,13,17,28-五氮杂-20,25-二硫杂-三环[15,5,5,1~(7,11)]-廿八-7,9,11(28)三烯(2).     

三种新型二苯砜氮杂环蕃N,N’-二对甲苯磺酰基-1,m-二氮杂[m.1]对环蕃-n-砜的合成与表征(m＝8,10,12; n＝15,17,19)

以N,N’-二对甲苯磺酰基-4,4’-二氨基二苯砜与二溴代烷为原料, 高度稀释条件下合成了三种新型有硫原子桥连的氮杂环蕃N,N’-二对甲苯磺酰基-1,8-二氮杂[8.1]对环蕃-15-砜(C); N,N’-二对甲苯磺酰基-1,10-二氮杂[10.1]对环蕃-17-砜(D); N,N’-二对甲苯磺酰基-1,12-二氮杂[12.1]对环蕃-19-砜(E). 提供了三种环蕃化合物的合成方法. 用IR, 1H NMR和元素分析证实了新化合物结构. 分析了化合物D的单晶结构数据, 为环蕃化合物的空间结构研究提供了晶体学依据.     

含吡啶环系西佛碱大环配合物和氮杂大环自由配体的合成

2,6-二羟甲基吡啶(1)经活性MnO_2氧化得到2,6-二甲酰基吡啶(2)。邻硝基苯酚与N-取代的二(氯乙基)胺在DMF溶液中反应,得到N-取代的1,5-二(邻硝基苯氧基)-3-氮杂戊烷(3a～3c),再经水合肼/Raney Ni还原,获得N-取代的1,5-二(邻氨基苯氧基)-3-氮杂戊烷(4a～4c)。利用Ba~(2 )作为模板离子,(2)分别与(4a～4c)反应,合成了一类新的含吡啶环系西佛碱大环配合物Ⅰ～Ⅲ,配合物Ⅰ、Ⅲ经与NaBH_4的乙醇溶液还原解络,得到氮杂大环自由配体Ⅳ和Ⅴ。所有西佛碱大环配合物和氮杂大环自由配体均经元素分析、IR、~1H NMR、MS等证实了它们的结构和组成。     

2-O-苄基-3,5-内醚-α和β-D-木呋喃甲基甙的合成

本文报导一对具有2,6-二氧杂双环[3.2.0]庚烷骨架的四元环内醚型戊糖甙差向异构体的合成.其关键化合物2-O-苯甲基-3,5-二-O-对甲苯磺酰基-α-和β-D-木呋喃甲基甙(S)、2-O-苯甲基-5-O-对甲苯磺酰基-α-D-木呋喃甲基甙及其3-O-乙酰基衍生物均以结晶形固体制得,由这些结晶分别制得标题化合物.     

含吡啶环系西佛碱大环配合物和氮杂大环自由配体的合成

2, 6-二羟甲基吡啶(1)经活性MnO~2氧化得到2, 6-二甲酰基吡啶(2)。邻硝基苯酚与N-取代的二(氯乙基)胺在DMF溶液中反应, 得到N-取代的1, 5-二(邻硝基苯氧基)-3-氮杂戊烷(3a～3c), 再经水合肼/Raney Ni还原, 获得N-取代的1, 5-二(邻氨基苯氧基)-3-氮杂戊烷(4a～4c)。利用Ba^2^+作为模板离子, (2)分别与(4a～4c)反应, 合成了一类新的含吡啶环系西佛碱大环配合物I-III, 配合物I、III与NaBH~4的乙醇溶液还原解络, 得到氮杂大环自由配体IV和V。所有西佛碱大环配合物和氮杂大环自由配体均经元素分析、IR、^1H NMR、MS等证实了它们的结构和组成。     

含取代噻吩环吡啶酰胺分子的微波合成与光谱表征

利用无溶剂微波合成法制备了两种新颖的取代噻吩基修饰吡啶酰胺分子吡啶-2,6-二[N-(2'-噻吩基甲基)甲酰胺](L1)和吡啶-2,6-二[N-(2'-噻吩基乙基)甲酰胺](L2),其合成过程无需溶剂,反应速度快,操作简单,节能环保。通过元素分析、1H-NMR、13C-NMR、IR及UV等表征手段对目标化合物L1和L2的分子结构进行了确认,对化合物的核磁谱线、红外特征吸收峰及紫外最大吸收峰进行了归属分析,丰富了吡啶酰胺类化合物的光谱数据。     

N-三甲基硅基对甲苯磺酰胺与对甲苯磺酸酯的反应

报道了3-氧杂-1,5-二戊醇二对甲苯磺酸酯及1,4-丁二醇二对甲苯磺酸酯与N-三甲基硅基对甲苯磺酰胺在碱存在下反应分别得到N-对甲苯磺酰基吗啡啉和N-对甲苯磺酰基四氢吡咯这一新的有机硅胺与磺酸酯的反应,在相同条件下N-三甲基硅基-对甲苯磺酰胺与对甲苯磺酸甲酯反应后仅得到N-甲基对甲苯磺酰胺,对此反应提出了可能的反应途径。     

含吡啶环的[1,3,4]噁二唑类化合物的合成及表征

2,6-二甲基吡啶-3,5-二甲酸二乙酯在乙醇中与水合肼反应生成5-甲酰肼基-2,6-二甲基吡啶甲酸乙酯和2,6-二甲基吡啶-3,5-双酰肼, 使其与取代的苯甲醛反应, 得到相应的腙, 最后在N-溴代丁二酰亚胺(NBS)作用下成环. 化合物的结构分别通过了¹H NMR, IR, MS, 元素分析确证.     

Coordination Compounds of Schiff-Base Ligands Derived from Diaminomaleonitrile (DMN): Mononuclear, Dinuclear, and Macrocyclic Derivatives

Copper(II) and V(IV)O complexes of an open chain (1:2) Schiff-base ligand (H(2)L1), derived by the template condensation of diaminomaleonitrile (DMN) and salicylaldehyde, and dicopper(II) complexes of (2:2) macrocyclic Schiff-base ligands derived by template condensation of diformylphenols and diaminomaleonitrile, have been synthesized and studied. Structures have been established for the first time for mononuclear Cu(II) and V(IV)O derivatives of the open chain ligand H(2)L1 (1:2), a dinuclear macrocyclic Cu(II) complex derived from a 2:2 macrocyclic ligand (H(2)M1), and the half-condensed 1:1 salicylaldehyde ligand (H(2)L2). [Cu(L1)] (1) (L1 = C(18)H(10)N(4)O(2)) crystallized in the monoclinic system, space group P2(1)/n (No. 14), with a = 11.753(6) ?, b = 7.708(5) ?, c = 16.820(1) ?, and Z = 4. [VO(L1)(DMSO] (2) crystallized in the orthorhombic system, space group Pbca (No. 61), with a = 22.534(9) ?, b = 23.31(1) ?, c = 7.694(5) ?, and Z = 8. H(2)L2 (C(18)H(8)N(4)O) (3) crystallized in the monoclinic system, space group P2(1)/c (No. 14), with a = 13.004(6) ?, b = 11.441(7) ?, c = 7.030(4) ?, and Z = 4. [Cu(2)(M3)](CH(3)COCH(3)) (4) (M3 = C(32)H(24)N(8)O(4)) crystallized in the monoclinic system, space group C2/c (No. 15), with a = 38.33(2) ?, b = 8.059(4) ?, c = 22.67(2) ?, and Z = 8. [Cu(L3)(DMSO)] (5) (L3 = C(20)H(14)N(2)O(4)) crystallized in the triclinic system, space group P&onemacr; (No. 2), with a = 10.236(4) ?, b = 13.514(4) ?, c = 9.655(4) ?, and Z = 2. 4 results from the unique addition of two acetone molecules to two imine sites in [Cu(2)(M1)](ClO(4))(2) (M1 = 2:2 macrocyclic ligand derived from template condensation of DMN and 2,6-diformyl-4-methylphenol). 4 has extremely small Cu-OPh-Cu bridge angles (92.0, 92.8 degrees ), well below the expected lower limit for antiferromagnetic behavior, but is still antiferromagnetically coupled (-2J = 25.2 cm(-)(1)). This behavior is associated with a possible antiferromagnetic exchange term that involves the conjugated framework of the macrocyclic ligand itself. The ligand L3 in 5 results from hydrolysis of M1 on recrystallization of [Cu(2)(M1)](ClO(4))(2) from undried dimethyl sulfoxide.     

Structural studies and anticancer activity of a novel (N6O4) macrocyclic ligand and its Cu(II) complexes

A novel (N6O4) macrocyclic ligand (L) and its Cu(II) complexes have been prepared and characterized by elemental analysis, spectral, thermal (TG/DTG), magnetic, and conductivity measurements. Quantum chemical calculations have also been carried out at B3LYP/6-31+G(d,p) to study the structure of the ligand and one of its complexes. The results show a novel macrocyclic ligand with potential amide oxygen atom, amide and amine nitrogen atoms available for coordination. Distorted square pyramidal ([Cu(L)Cl]Cl·2.5H2O (1), [Cu(L)NO3]NO(3)·3.5H2O (2), and [Cu(L)Br]Br·3H2O (4) and octahedral ([Cu(L)(OAc)2]·5H2O (3)) geometries were proposed. The EPR data of 1, 2, and 4 indicate d1x2(-y)2 ground state of Cu(II) ion with a considerable exchange interaction. The measured cytotoxicity for L and its complexes (1, 2) against three tumor cell lines showed that coordination improves the antitumor activity of the ligand; IC50 for breast cancer cells are ≈8.5, 3, and 4 μg/mL for L and complexes (1) and (2), respectively.     

二十四元六氮大环双核铜(I)配合物的氧化去甲基作用: 单加氧酶的模拟

以5-溴-2-甲氧基-1, 3-苯二甲醛与二乙烯三胺通过[2+2]缩合,合成了一个新的六氮杂二十四元大环配体, 并在[Cu(CH3CN)4]ClO4存在下生成Cu(I)大环配合物, 然后在空气(或氧气)中氧化, 得到了新的大环双核Cu(II)配合物, 用多种方法对其进行了表征, 用1H NMR谱等方法鉴定了氧化产物。实验结果表明: 在Cu(I)配合物氧化过程中,能使配体环上的一个甲氧基发生断裂, 形成苯氧桥和水桥联的Cu(II)配合物。在木质素酶等单加氧酶的氧化过程中也伴随着氧化去甲基作用。本文首次用大环配合物对这一过程进行了模拟, 并测定了氧化反应中的吸氧量和吸氧速率常数。     

Spectroscopic, redox and biological activities of transition metal complexes with ons donor macrocyclic ligand derived from semicarbazide and thiodiglycolic acid

A novel macrocyclic Schiff base ligand (2,5,9,12,14,18-hexaoxo-7,16-dithia-1,3,4,10,11,13-hexaazacycloocta-decane (H6L) with N4S2 coordinating sites was prepared by the reaction of the semicarbazide and thiodiglycolic acid. The transition metal complexes with macrocyclic ligand were synthesized and characterized by elemental analyses, magnetic susceptibility measurements, molar conductance, IR, electronic, and EPR spectral studies. Mass, 1H NMR and IR spectral techniques suggest the structural features of macrocyclic ligand. Magnetic and electronic spectral studies suggest an octahedral geometry of complexes. Electrochemical behaviour of cobalt, nickel and copper complexes were determined by cyclic voltammetry. The cyclic voltammogram of the copper complex at room temperature shows a quasi-reversible peaks for Cu(III)-->Cu(II) and Cu(II)-->Cu(I) couples. The macrocyclic ligand and its complexes show growth inhibitory activity against pathogenic bacteria and plant pathogenic fungi A. niger, A. alternata and P. variotii. Most of the complexes have higher activities than that of free ligand.     

含萘磺酰基大环多胺与Cu(II)和DNA作用的荧光性能研究

以1,4,7,10-四氮杂环十二烷(Cyclen)为原料,合成了含有萘磺酰基的大环多胺,其结构经1H NMR、MS、元素分析等表征。用荧光光谱法测定了大环多胺与Cu(II)在不同pH下的配位情况,研究了大环多胺激发和发射波长,配体浓度与吸光度的线性关系;Cu(II)、小牛胸腺嘧啶DNA对大环多胺荧光性能的影响。     

Synthesis and Crystal Structure of Dinuclear Copper Complex[Cu（CH2O（C6H4）N=C（C6H4）O）（Py]2

1 INTRODUCTION Synthesis of transition metal complexes with Schiff-base has been a subject of considerable importance [1,2]. They are not only good complexing agents for Schiff-base, but also good bactericide and antitumour agent [3,4]. At present, there is a spectacular growth in this field. Recently, some bridged binuclear complexes have received much attention on account of their biological relevance and condensed-phase magnetic properties[5,6]. Especially, the complexes containin…     

Ferromagnetic coupling promoted by kappa3N:kappa2N bridging system

Syntheses, structures, and magnetic properties of novel trinuclear complexes of the same motif [M{Cu(pz2bg)2}M]4+ (M = CuII, NiII, CoII, MnII), catena-[Cu2{Cu(pz2bg)2}(Hpz)2(PhSO3)2](PhSO3)2.4H2O (2.4H2O), [Ni2{Cu(pz2bg)2}(MeOH)2(H2O)4](NO3)4 (3), [Co2{Cu(pz2bg)2}(NO3)2(EtOH)2](NO3)2 (4), and [Mn2{Cu(pz2bg)2}(NO3)4(MeCN)2] (5), which include the complex ligand [Cu(pz2bg)2] (1), are reported (Hpz = pyrazole, pz2bg- = di(pyrazolecarbimido)aminate; bispyrazolyl derivative of biguanidate). The reaction of Cu(ClO4)2.6H2O, sodium dicyanamide, Hpz, and PhSO3H.H2O (1:2:4:4) in MeOH yielded blue crystals of [Cu2(1)(Hpz)2(PhSO3)2](PhSO3)2.4H2O (2.4H2O). In 2, the tricopper(II) units, which consist of two Cu(II) ions bridged by 1, are linked by benzenesulfonate anions to form a ladder structure. Complex 1 was isolated by removing the terminal Cu(II) ions from 2 with use of Na(4)edta. Complexes 3-5 were obtained by the reaction of 1 with an excess of each M(II) ion. In 2-5, the adjoining metal ions are ferromagnetically coupled via the pz2bg- ligand with J values of +7.2(1), +7.5(1), +2.7(1), and +0.3(1) cm(-1), respectively, using a spin Hamiltonian H = -2J(S(M1)S(Cu) + S(Cu)S(M2)). The ferromagnetic interaction was attributed to the strict orthogonality of magnetic dsigma orbitals, which are controlled by the kappa3N:kappa2N bridging geometry of the pz2bg- ligands.     

Syntheses,structures, and properties of imidazolate-bridged Cu(II)-Cu(II) and Cu(II)-Zn(II) dinuclear complexes of a single macrocyclic ligand with two hydroxyethyl pendants

The imidazolate-bridged homodinuclear Cu(II)-Cu(II) complex, [(CuimCu)L]ClO(4).0.5H(2)O (1), and heterodinuclear Cu(II)-Zn(II) complex, [(CuimZnL(-)(2H))(CuimZnL(-)(H))](ClO(4))(3) (2), of a single macrocyclic ligand with two hydroxyethyl pendants, L (L = 3,6,9,16,19,22-hexaaza-6,19-bis(2-hydroxyethyl)tricyclo[22,2,2,2(11,14)]triaconta-1,11,13,24,27,29-hexaene), have been synthesized as possible models for copper-zinc superoxide dismutase (Cu(2),Zn(2)-SOD). Their crystal structures analyzed by X-ray diffraction methods have shown that the structures of the two complexes are markedly different. Complex 1 crystallizes in the orthorhombic system, containing an imidazolate-bridged dicopper(II) [Cu-im-Cu](3+) core, in which the two copper(II) ions are pentacoordinated by virtue of an N4O environment with a Cu.Cu distance of 5.999(2) A, adopting the geometry of distorted trigonal bipyramid and tetragonal pyramid, respectively. Complex 2 crystallizes in the triclinic system, containing two similar Cu-im-Zn cores in the asymmetric unit, in which both the Cu(II) and Zn(II) ions are pentacoordinated in a distorted trigonal bipyramid geometry, with the Cu.Zn distance of 5.950(1)/5.939(1) A, respectively. Interestingly, the macrocyclic ligand with two arms possesses a chairlike (anti) conformation in complex 1, but a boatlike (syn) conformation in complex 2. Magnetic measurements and ESR spectroscopy of complex 1 have revealed the presence of an antiferromagnetic exchange interaction between the two Cu(II) ions. The ESR spectrum of the Cu(II)-Zn(II) heterodinuclear complex 2 displayed a typical signal for mononuclear trigonal bipyramidal Cu(II) complexes. From pH-dependent ESR and electronic spectroscopic studies, the imidazolate bridges in the two complexes have been found to be stable over broad pH ranges. The cyclic voltammograms of the two complexes have been investigated. Both of the two complexes can catalyze the dismutation of superoxide and show rather high activity.     

Synthesis, molecular modeling and spectroscopic characterization of nickel(II), copper(II), complexes of new 16-membered mixed-donor macrocyclic schiff base ligand incorporating a pendant alcohol function

Complexes of Cu(II) and Ni(II) of the composition [M(L)X] [where M=Ni(II), Cu(II) and X=Cl-, NO3-, CH3COO-] were synthesized with 1,5-dioxo-9,10-diaza-3,ol-tribenzo-(7,6,10,11,14,15) peptadecane, a N2O2 macrocyclic ligand. The complexes were characterized by elemental analysis, molar conductance measurements, UV-vis, IR, 1H NMR, 13C NMR, EPR and molecular modeling studies. All the complexes are non-electrolyte in nature. On the basis of spectral studies, an octahedral geometry has been assigned for Ni(II) complexes and a tetragonal geometry for Cu(II) complexes.     

Synthesis and characterisation of transition metal halide complexes of the xylyl-distibine, 1,2-bis(dimethylstibanylmethyl)benzene

Complexes of the title ligand with Cu(I), Ag(I), Au(I), Pd(II), Pt(II), Rh(III), and rare examples with Ni(II) and Co(III) have been prepared and characterised by analysis, IR, UV-vis, 1H, 63Cu and 59Co NMR spectroscopy and ES+ mass spectrometry as appropriate. The structures of [Cu[1,2-C6H4(CH2SbMe2)2]2]BF4, [PtCl2[1,2-C6H4(CH2SbMe2)2]], [M[1,2-C6H4(CH2SbMe2)2]2][PF6]2 (M = Pd or Pt), and [NiI[1,2-C6H4(CH2SbMe2)2]2]ClO4 have been determined, and the varying chelate bite and conformations of the xylyl backbone in these structures are discussed. Despite the unfavourable seven-membered chelate ring and the large soft antimony donors, 1,2-C6H4(CH2SbMe2)2 proves to be a surprisingly good ligand for late transition metals in medium oxidation states.